These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16800391)

  • 41. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women.
    Kingsberg S
    J Sex Med; 2007 Mar; 4 Suppl 3():227-34. PubMed ID: 17394595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Global Consensus Position Statement on the Use of Testosterone Therapy for Women.
    Davis SR; Baber R; Panay N; Bitzer J; Perez SC; Islam RM; Kaunitz AM; Kingsberg SA; Lambrinoudaki I; Liu J; Parish SJ; Pinkerton J; Rymer J; Simon JA; Vignozzi L; Wierman ME
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4660-4666. PubMed ID: 31498871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Androgen insufficiency in women: summary of critical issues.
    Braunstein GD
    Fertil Steril; 2002 Apr; 77 Suppl 4():S94-9. PubMed ID: 12007911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New attitudes to sexuality in the menopause: clinical evaluation and diagnosis.
    Nappi RE
    Climacteric; 2007 Oct; 10 Suppl 2():105-8. PubMed ID: 17882684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of androgen therapy.
    Burger HG; Davis SR
    Best Pract Res Clin Obstet Gynaecol; 2002 Jun; 16(3):383-93. PubMed ID: 12099669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Androgen Therapy in Women.
    Vegunta S; Kling JM; Kapoor E
    J Womens Health (Larchmt); 2020 Jan; 29(1):57-64. PubMed ID: 31687883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hypoactive sexual desire and testosterone deficiency in men].
    Lejeune H; Huyghe É; Droupy S
    Prog Urol; 2013 Jul; 23(9):621-8. PubMed ID: 23830256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What is the rationale for androgen therapy for women?
    Papalia MA; Davis SR
    Treat Endocrinol; 2003; 2(2):77-84. PubMed ID: 15871544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of hypoactive sexual desire disorder.
    Segraves RT
    Adv Psychosom Med; 2008; 29():23-32. PubMed ID: 18391555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormonal changes in menopause and implications on sexual health.
    Schwenkhagen A
    J Sex Med; 2007 Mar; 4 Suppl 3():220-6. PubMed ID: 17394594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Testosterone therapy for postmenopausal women: efficacy and safety.
    Somboonporn W
    Semin Reprod Med; 2006 Apr; 24(2):115-24. PubMed ID: 16633985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Androgen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction: androgen and questionnaire results.
    Munarriz R; Talakoub L; Flaherty E; Gioia M; Hoag L; Kim NN; Traish A; Goldstein I; Guay A; Spark R
    J Sex Marital Ther; 2002; 28 Suppl 1():165-73. PubMed ID: 11898698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Androgens and sexual behaviour in women using oral contraceptives.
    Bancroft J; Davidson DW; Warner P; Tyrer G
    Clin Endocrinol (Oxf); 1980 Apr; 12(4):327-40. PubMed ID: 6991164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlates of circulating androgens in mid-life women: the study of women's health across the nation.
    Santoro N; Torrens J; Crawford S; Allsworth JE; Finkelstein JS; Gold EB; Korenman S; Lasley WL; Luborsky JL; McConnell D; Sowers MF; Weiss G
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4836-45. PubMed ID: 15840738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B: Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction.
    Guay A; Jacobson J; Munarriz R; Traish A; Talakoub L; Quirk F; Goldstein I; Spark R
    Int J Impot Res; 2004 Apr; 16(2):121-9. PubMed ID: 14973532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LEI (Lack of tEstosterone Impact) survey in a clinical sample with surgical menopause.
    Nappi RE; Lello S; Melis GB; Albani F; Polatti F; Genazzani AR
    Climacteric; 2009 Dec; 12(6):533-40. PubMed ID: 19905905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Androgens, well-being and libido in women].
    van Santbrink EJ; Gianotten WL; Fauser BC
    Ned Tijdschr Geneeskd; 2003 Sep; 147(39):1899-904. PubMed ID: 14560687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Testosterone therapy in premenopausal women.
    Kalantaridou SN; Calis KA
    Semin Reprod Med; 2006 Apr; 24(2):106-14. PubMed ID: 16633984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Testosterone for women: necessary or noxious?
    Katz A
    AWHONN Lifelines; 2006; 10(3):208-9. PubMed ID: 16792707
    [No Abstract]   [Full Text] [Related]  

  • 60. The safety of testosterone therapy in women.
    Al-Imari L; Wolfman WL
    J Obstet Gynaecol Can; 2012 Sep; 34(9):859-865. PubMed ID: 22971455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.